ENTITY
Corcept Therapeutics

Corcept Therapeutics (CORT US)

3
Analysis
Health CareUnited States
Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company's lead product modulates the effect of cortisol, also known as the "stress hormone", by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.
more
Company Event19 Feb 2026 05:00 • Upcoming
Add To Calendar
Company Event05 Nov 2025 06:00 • Latest
Company Event01 Aug 2025 05:00
Company Event06 May 2025 05:00
Company Event27 Feb 2025 06:00
x